Showing results (161-170 of 341) with videos related to

Sort By:
Pageof 35
JACC. Cardiovascular Interventions|February 25, 2012
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) TrialsPeter Damman, Nan van Geloven, Lars Wallentin, et al.
JACC. Advances|January 29, 2026
Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-PooledNitish K Dhingra, Javed Butler, Stefan D Anker, et al.
European Journal of Heart Failure|March 5, 2024
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
JACC. Heart Failure|June 7, 2022
Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-PreservedJames L Januzzi, Javed Butler, Faiez Zannad, et al.
European Heart Journal|December 8, 2022
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Bhm, Stefan Anker, Felix Mahfoud, et al.
European Journal of Heart Failure|September 16, 2025
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-ReducedMichael Böhm, Javed Butler, Amr Abdin, et al.
European Heart Journal|October 26, 2012
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studiesStuart J Pocock, Cono A Ariti, John J V McMurray, et al.
European Journal of Heart Failure|April 8, 2024
Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
Journal of the American College of Cardiology|July 3, 2007
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke DatabankG Michael Felker, Larry A Allen, Stuart J Pocock, et al.
Pageof 35